News

Birmingham patient among first to receive COVID-19 convalescent plasma

One of the first people to receive COVID-19 convalescent plasma has spoken about their experience and urged people to donate. Ahmed Bhayat from Handsworth in Birmingham, was one of the first people in the UK to receive a transfusion of convalescent plasma, while he was fighting for his life in the critical care unit at … Continue reading “Birmingham patient among first to receive COVID-19 convalescent plasma”

Birmingham to play key role in ground-breaking new study into long-term health impacts of coronavirus

A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched, with support from Birmingham Health Partners. The PHOSP-COVID study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 … Continue reading “Birmingham to play key role in ground-breaking new study into long-term health impacts of coronavirus”

Over the counter anti-inflammatory drugs could be damaging the health of runners

Anti-inflammatory drugs, such as over-the-counter ibuprofen, are commonly used by runners to ease post-exercise aches, pains or injuries, but carry a risk of harm according to a new study into the use of the pain killers by recreational runners in the UK. Non-steroidal anti-inflammatories (NSAIDs) block the production of inflammatory chemicals called prostaglandins, which reduces … Continue reading “Over the counter anti-inflammatory drugs could be damaging the health of runners”

New sequencing tech will help us decipher disease mechanisms

New technologies capable of sequencing single molecules in fine detail will help scientists better understand the mechanisms of rare nucleotides thought to play an important role in the progression of some diseases. A review paper, led by a scientist at BHP founder member the University of Birmingham, describes how emerging sequencing technologies will transform our … Continue reading “New sequencing tech will help us decipher disease mechanisms”

Grant awarded for trial into respiratory disease

Alice Turner, Professor of Respiratory Medicine in the Institute of Applied Health Research, and her team have been successfully awarded a £650,000 NIHR Health Technology Assessment trial grant to test ambulatory oxygen in patients with idiopathic pulmonary fibrosis. Over three years the ‘OxyPuf’ trial plans to assess the benefit, if any, of ambulatory oxygen in the … Continue reading “Grant awarded for trial into respiratory disease”